Cohen Yuval, CEO of Corbus Pharmaceuticals Holdings CRBP, has filed 0 purchases and 12 sales on the open market. Over the past 12 months that comes to a net sale of $579.1K. The latest trade was on 02/13.

CY

CY

Cohen Yuval

CEO

Company

Corbus Pharmaceuticals Holdings CRBP

First filing

23/02/15

Trades

39 trades

Buys / sales

0 / 12

12-month net buying

−$579.1K

Last trade

02/13

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Corbus Pharmaceuticals HoldingsCRBP	Open-market sale10b5-1 plan	02/13	02/18	13,871 sh	$7.78	$107,916.38	−7.4%
Corbus Pharmaceuticals HoldingsCRBP	Open-market sale10b5-1 plan	25/10/24–25/10/27	25/10/27	27,633 sh2 trades	$17.05avg.	$471,203.82	−16.7%
Corbus Pharmaceuticals HoldingsCRBP	Open-market sale10b5-1 plan	25/02/14	25/02/18	7,134 sh	$8.76	$62,493.84	−4.9%
Corbus Pharmaceuticals HoldingsCRBP	Open-market sale10b5-1 plan	24/06/14–24/06/18	24/06/18	63,358 sh8 trades	$46.57avg.	$2,950,695.07	−45.1%